Neurocrine Bioscience buy Piper Sandler
Start price
29.10.25
/
50%
€117.85
Target price
29.10.26
€153.67
Performance (%)
-4.37%
Price
28.01.26
€112.70
Summary
This prediction is currently active. With a performance of -4.37%, the BUY prediction by Piper_Sandler is trending in the wrong direction. This prediction currently runs until 29.10.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.761% | -2.761% |
| iShares Core DAX® | 0.170% | 2.184% |
| iShares Nasdaq 100 | 0.515% | 0.370% |
| iShares Nikkei 225® | 1.614% | 6.357% |
| iShares S&P 500 | -0.719% | -0.275% |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Piper Sandler from $175.00 to $179.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
-2.21%
28.01.26
28.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€136.35
06.05.26
06.05.26
6.42%
28.01.26
28.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€130.60
23.12.24
23.12.24
€153.97
23.12.25
23.12.25
-6.36%
24.12.25
24.12.25